|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
8.76/13.20
|
企业价值
134.44B
|
资产负债 |
每股账面净值
50.33
|
现金流量 |
现金流量率
0.03
|
损益表 |
收益
20.50B
|
每股收益
52.20
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/15 09:46 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States. |